デフォルト表紙
市場調査レポート
商品コード
1013730

消費者向けDNA (遺伝子) 検査市場 - 予測:2021年~2026年

Consumer DNA (Genetic) Testing Market - Forecasts from 2021 to 2026

出版日: | 発行: Knowledge Sourcing Intelligence | ページ情報: 英文 106 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.41円
消費者向けDNA (遺伝子) 検査市場 - 予測:2021年~2026年
出版日: 2021年04月02日
発行: Knowledge Sourcing Intelligence
ページ情報: 英文 106 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

消費者向けDNA (遺伝子) 検査市場の市場規模は、2019年の4億8,790万9,000米ドルから、2026年には10億9,557万9,400米ドルに達し、CAGRで12.25%の成長が予測されています。市場は、消費者向け(DTC)遺伝子検査、身元確認、その他の関連要因に対する需要の急増により、今後数年間で急増すると予想されています。

当レポートでは、世界の消費者向けDNA (遺伝子) 検査市場について調査分析し、市場力学、セグメント別の市場分析、競合環境、主要企業などについて、体系的な情報を提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場促進要因
  • 市場抑制要因
  • ポーターのファイブフォース分析
  • 業界のバリューチェーン分析

第5章 世界の消費者向けDNA (遺伝子) 検査市場分析:性別

  • イントロダクション
  • 男性
  • 女性

第6章 世界の消費者向けDNA (遺伝子) 検査市場分析:年齢層別

  • イントロダクション
  • 0~15歳
  • 15~30歳
  • 30~60歳
  • 60歳超

第7章 世界の消費者向けDNA (遺伝子) 検査市場分析:用途別

  • イントロダクション
  • 病気発症リスク
  • 身元調査
  • 好奇心

第8章 世界の消費者向けDNA (遺伝子) 検査市場分析:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 南米
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • その他
  • 中東・アフリカ
  • アジア太平洋地域
    • 日本
    • 中国
    • その他

第9章 競合環境と分析

  • 主要企業と戦略的分析
  • 新興企業と市場の収益性
  • 合併、買収、合意、コラボレーション
  • ベンダーの競合マトリックス

第10章 企業プロファイル

  • Quest Diagnostics Inc.
  • Positive Bioscience
  • Mapmygenome India
  • MyMedLab
  • Laboratory Corporation of America
  • Gene by Gene
  • Counsyl
  • Color Genomics
  • 23andMe
  • Illumina
  • Ancestry
目次

The global consumer DNA (Genetic) testing market is expected to grow at a compound annual growth rate of 12.25% over the forecast period to reach a market size of US$1,095.5794 million in 2026, from US$487.909 million in 2019. Genetic or DNA testing usually refers to medical tests that examine and evaluates the changes in chromosomes, genes, or several types of proteins to help a person's chance of developing one or rule out a suspected genetic condition. The market is expected to surge in the coming years, due to the rise in the demand for direct-to-consumer genetic testing, identity seeking, and other related factors. Increasing and raising awareness about novel developments and advancements in the DNA testing market is expected to play a major role in the overall market growth. Major companies such as Ancestry and 23andMe have been investing a significant sum of capital to develop advanced and innovative superior and excellent direct-to-consumer genetic testing and other related solutions. Moreover, the growth in genetic ancestry testing is also expected to play a major and imperative role in the market growth, during the forecast period. These trends are expected to have a positive impact on the market, in the coming years.

A rise in genetic ancestry testing.

Genetic ancestry testing is defined as a way for an individual to learn more about his family's genealogy or want to go beyond data collection from historical documentation. There has been a surge in the demand for ancestry testing, with the use of cheek swabs or saliva DNA test kits, especially in the regions like Europe and North America. According to the data given by the MIT Institute and Technology, more than 26 million customers had added their respective DNA to four major health databases and commercial ancestry. Moreover, according to Ancestry and 23andMe, two of the major players in the market, the companies have now a collection of some of the world's biggest collections of human DNAs. With the affordable pricing of around US$59, these DNA tests offer a plethora of entertainment, a major chance of discovering family and ancestry secrets, such as estranged siblings. Ancestry also claimed that they had registered a record Thanksgiving sale in November 2018 and sold a total number of test kits at around 14 million. Moreover, other companies are also making significant developments in the market. For instance, Gene By Gene, one of the major firms in the market, had stated that its family tree DNA ancestry database contains approx. 2 million people. Another company, known as MyHeritage, a major Israeli firm, had stated that their database has around 2.5 million profiles. Moreover, the growth in direct-to-consumer DNA testing is also expected to have a major impact on the market. According to several official figures, there had been an expectation of sales of around 100 million kits by the year 2021. A plethora of companies has been providing DNA testing services to their customers, in the past few years. For instance, in December 2020, MyHeritage, a major global service for identifying your past and future company, announced the launch of genetic groups. The genetic groups would be able to identify and find ancestral origins with high-resolution data of around 2100 geographic regions. This development is expected to enhance the company's market share, in the coming years. Other players are also making significant developments in the market. In January 2021, myDNA, a major Australian genomics company, announced a merger with FamilyTreeDNA, a US-based consumer DNA test company, and with Gene By Gene, the parent company of FamilyTreeDNA. The innovative merger of these companies is expected to be a major development for the market, as the companies would aim to focus on the enhancement of a scientific foundation for personalized and actionable insights. Asia Pacific region is expected to have a major share in the market, due to the rise in the number of start-ups and increasing excitement about ancestral DNA testing.

Novel Developments.

  • In May 2021, GB HealthWatch, a major player in translational genomics, announced the launch of their novel and advanced GBInsight Nutritional Genomics genetic analysis panel and testing as a core and major component of their healthcare platform. The company, with the novel addition, had been planning to expand into the area of genetics-based and precision preventive healthcare. This development is expected to have a positive impact on the market, in the coming years.
  • In May 2021, 23andMe, a major player in the market, announced that it had been merging with VG Acquisition Corporation, a special purpose acquisition company. According to 23andMe, their company had been valued at US$3.5 billion and will bet the consumer research and genetics company with approx. US$759 million in extra and additional cash. This development is expected to enhance the market, during the forecast period.
  • In October 2020, Blackstone, a private equity firm, announced that it would acquire a majority stake in a major DNA testing company, called Ancestry. Blackstone had stated that it would invest behind functionality further data and novel product development and advancement across Ancestry's market-leading platform.
  • In August 2020, Ancestry announced that it would step up and advanced its consumer DNA testing using novel and next-generation sequencing programs and technologies developed by a major player in the market, known as Quest Diagnostics. Ancestry had been relaunching its flagship AncestryHealth service with more innovative, safer, and advanced genetic or DNA testing technology to alert customers, which are at the risk of having or developing certain inheritable diseases.
  • In December 2020, Genebox, a major Chinese start-up, announced that it had raised a sum of around tens of millions in the series A round, which was led by Centurium Capital. The company had already raised more than US$21 million in their angel round, which was led by Dashenlin Pharmaceutical, a major drug retail chain. This development is expected to have a positive impact on China's DNA testing market, in the coming years.

Segmentation:

  • By Gender
  • Male
  • Female
  • By Age Group
  • 0-15 Years
  • 15-30 Years
  • 30-60 years
  • Above 60 Years
  • By Application
  • Disease Risk
  • Identity Seeking
  • Curiosity Driven
  • By Geography
  • North America
  • USA
  • Canada
  • South America
  • Europe
  • UK
  • Germany
  • France
  • Others
  • Middle East and Africa
  • Asia Pacific
  • Japan
  • China
  • Others

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. Global Consumer DNA (Genetic) Testing Market Analysis, By Gender

  • 5.1. Introduction
  • 5.2. Male
  • 5.3. Female

6. Global Consumer DNA (Genetic) Testing Market Analysis, By Age Group

  • 6.1. Introduction
  • 6.2. 0-15 Years
  • 6.3. 15-30 Years
  • 6.4. 30-60 years
  • 6.5. Above 60 Years

7. Global Consumer DNA (Genetic) Testing Market Analysis, By Application

  • 7.1. Introduction
  • 7.2. Disease Risk
  • 7.3. Identity Seeking
  • 7.4. Curiosity Driven

8. Global Consumer DNA (Genetic) Testing Market Analysis, by Geography

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
  • 8.3. South America
  • 8.4. Europe
    • 8.4.1. UK
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Others
  • 8.5. The Middle East and Africa
  • 8.6. Asia Pacific
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. Others

9. Competitive Environment and Analysis

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Emerging Players and Market Lucrativeness
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Vendor Competitiveness Matrix

10. Company Profiles

  • 10.1. Quest Diagnostics Inc.
  • 10.2. Positive Bioscience
  • 10.3. Mapmygenome India
  • 10.4. MyMedLab
  • 10.5. Laboratory Corporation of America
  • 10.6. Gene by Gene
  • 10.7. Counsyl
  • 10.8. Color Genomics
  • 10.9. 23andMe
  • 10.10. Illumina
  • 10.11. Ancestry